Evaluation of 99mTc-ZIGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression
出版年份 2014 全文链接
标题
Evaluation of 99mTc-ZIGF1R:4551-GGGC affibody molecule, a new probe for imaging of insulin-like growth factor type 1 receptor expression
作者
关键词
Affibody molecule, IGF-1R, Peptide-based chelator, <sup>99m</sup>Tc, Biodistribution
出版物
AMINO ACIDS
Volume 47, Issue 2, Pages 303-315
出版商
Springer Nature
发表日期
2014-12-01
DOI
10.1007/s00726-014-1859-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Imaging of Platelet-Derived Growth Factor Receptor Expression in Glioblastoma Xenografts Using Affibody Molecule 111In-DOTA-Z09591
- (2014) V. Tolmachev et al. JOURNAL OF NUCLEAR MEDICINE
- Co-inhibition of epidermal growth factor receptor and insulin-like growth factor receptor 1 enhances radiosensitivity in human breast cancer cells
- (2013) Ping Li et al. BMC CANCER
- The strength of small: Improved targeting of Insulin-like Growth Factor-1 Receptor (IGF-1R) with F(ab′)2-R1507 fragments in Ewing sarcomas
- (2013) Emmy D.G. Fleuren et al. EUROPEAN JOURNAL OF CANCER
- The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancer
- (2013) Minoru Haisa JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- HAHAHA, HEHEHE, HIHIHI, or HKHKHK: Influence of Position and Composition of Histidine Containing Tags on Biodistribution of [99mTc(CO)3]+-Labeled Affibody Molecules
- (2013) Camilla Hofström et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Insulin Receptor/Insulin-Like Growth Factor Receptor Family as a Therapeutic Target in Oncology
- (2012) M. Pollak CLINICAL CANCER RESEARCH
- Targeting insulin-like growth factor in breast cancer therapeutics
- (2012) Michalis V. Karamouzis et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Liver uptake of radiolabeled targeting proteins and peptides: considerations for targeting peptide conjugate design
- (2012) Seyed Jalal Hosseinimehr et al. DRUG DISCOVERY TODAY
- [99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours
- (2012) Anna Orlova et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Tumor Targeting Using Affibody Molecules: Interplay of Affinity, Target Expression Level, and Binding Site Composition
- (2012) V. Tolmachev et al. JOURNAL OF NUCLEAR MEDICINE
- Depletion of the type 1 IGF receptor delays repair of radiation-induced DNA double strand breaks
- (2012) Benjamin W. Turney et al. RADIOTHERAPY AND ONCOLOGY
- Evaluation of a HER2-targeting affibody molecule combining an N-terminal HEHEHE-tag with a GGGC chelator for 99mTc-labelling at the C terminus
- (2012) Hanna Lindberg et al. TUMOR BIOLOGY
- Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507
- (2011) E. D. G. Fleuren et al. CLINICAL CANCER RESEARCH
- Use of a HEHEHE Purification Tag Instead of a Hexahistidine Tag Improves Biodistribution of Affibody Molecules Site-Specifically Labeled with99mTc,111In, and125I
- (2011) Camilla Hofström et al. JOURNAL OF MEDICINAL CHEMISTRY
- Imaging of Insulinlike Growth Factor Type 1 Receptor in Prostate Cancer Xenografts Using the Affibody Molecule 111In-DOTA-ZIGF1R:4551
- (2011) V. Tolmachev et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular Design and Optimization of 99mTc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties
- (2011) H. Wallberg et al. JOURNAL OF NUCLEAR MEDICINE
- Comparing the Epidermal Growth Factor Interaction with Four Different Cell Lines: Intriguing Effects Imply Strong Dependency of Cellular Context
- (2011) Hanna Björkelund et al. PLoS One
- The insulin-like growth factor-I receptor as an oncogene
- (2011) Haim Werner et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- HEHEHE-Tagged Affibody Molecule May Be Purified by IMAC, Is Conveniently Labeled with [99mTc(CO)3]+, and Shows Improved Biodistribution with Reduced Hepatic Radioactivity Accumulation
- (2010) Vladimir Tolmachev et al. BIOCONJUGATE CHEMISTRY
- Radionuclide Molecular Imaging Using Affibody Molecules
- (2010) Sara Ahlgren et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications
- (2010) J. Löfblom et al. FEBS LETTERS
- ImmunoSPECT and ImmunoPET of IGF-1R Expression with the Radiolabeled Antibody R1507 in a Triple-Negative Breast Cancer Model
- (2010) S. Heskamp et al. JOURNAL OF NUCLEAR MEDICINE
- Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls
- (2010) Vladimir Tolmachev et al. LANCET ONCOLOGY
- Kit formulation for 99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteine
- (2010) Sara Ahlgren et al. NUCLEAR MEDICINE AND BIOLOGY
- Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry
- (2009) V. Tolmachev et al. JOURNAL OF NUCLEAR MEDICINE
- Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine
- (2009) S. Ahlgren et al. JOURNAL OF NUCLEAR MEDICINE
- Predictive biomarkers for targeting insulin-like growth factor-I (IGF-I) receptor
- (2009) C. P. Carden et al. MOLECULAR CANCER THERAPEUTICS
- The Type 1 Insulin-Like Growth Factor Receptor Pathway
- (2008) M. M. Chitnis et al. CLINICAL CANCER RESEARCH
- The insulin receptor substrate-1: A biomarker for cancer?
- (2008) Renato Baserga EXPERIMENTAL CELL RESEARCH
- Alternative binding proteins: Affibody binding proteins developed from a small three-helix bundle scaffold
- (2008) Per-Åke Nygren FEBS Journal
- Evaluation of Maleimide Derivative of DOTA for Site-Specific Labeling of Recombinant Affibody Molecules
- (2007) Sara Ahlgren et al. BIOCONJUGATE CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started